Log In
Print this Print this

BIO 300

  Manage Alerts
Collapse Summary General Information
Company Humanetics Corp.
DescriptionRadioprotectant inhibitor of protein tyrosine kinase (PTK) and topoisomerase II (TOP2)
Molecular Target Protein tyrosine kinase (PTK) ; Topoisomerase II (TOP2)
Mechanism of ActionRadioprotectant
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationPoisoning
Indication DetailsPrevent and mitigate acute radiation syndrome (ARS); Treat and prevent acute radiation syndrome (ARS)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today